Title : Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway.

Pub. Date : 2021 Mar 10

PMID : 33514677






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson"s disease via PPARalpha-Dependent Astrocytic GDNF Pathway. Gemfibrozil peroxisome proliferator activated receptor alpha Mus musculus
2 Gemfibrozil-mediated protection of the nigrostriatal and locomotor activities in WT but not PPARalpha-/- mice from MPTP intoxication suggests that gemfibrozil needs the involvement of PPARalpha in protecting dopaminergic neurons. Gemfibrozil peroxisome proliferator activated receptor alpha Mus musculus
3 While investigating further mechanisms, we found that gemfibrozil stimulated the transcription of glial-derived neurotrophic factor (GDNF) gene in astrocytes via PPARalpha and that gemfibrozil protected nigral neurons, normalized striatal fibers and neurotransmitters, and improved locomotor activities in MPTP-intoxicated Gfaf cre mice, but not Gdnf Deltaastro mice lacking GDNF in astrocytes. Gemfibrozil peroxisome proliferator activated receptor alpha Mus musculus
4 Here, we delineate that gemfibrozil, a lipid-lowering drug, stimulates GDNF in astrocytes via peroxisome proliferator-activated receptor alpha (PPARalpha). Gemfibrozil peroxisome proliferator activated receptor alpha Mus musculus